We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

37 hedge funds and large institutions have $27.3M invested in Lumos Pharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 40 → 37 (-3)

15% less capital invested

Capital invested by funds: $32.1M → $27.3M (-$4.81M)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$950K
2
MA
Minerva Advisors
Pennsylvania
+$319K
3
Millennium Management
Millennium Management
New York
+$144K
4
Citadel Advisors
Citadel Advisors
Florida
+$111K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$48.5K

Top Sellers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
-$3.82M
2
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Texas
-$500K
3
DM
Deerfield Management
New York
-$331K
4
Renaissance Technologies
Renaissance Technologies
New York
-$182K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$173K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
26
CAPTRUST Financial Advisors
North Carolina
$4K – – –
UBS Group
27
UBS Group
Switzerland
$4K +$3.4K +362 +326%
ST
28
Sphinx Trading
Illinois
$3K +$2.6K +277 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$2K -$357 -38 -15%
CFGS
30
Concourse Financial Group Securities
Alabama
$1K – – –
EVM
31
Eaton Vance Management
Massachusetts
$1K – – –
Group One Trading
32
Group One Trading
Illinois
$1K – – –
Northwestern Mutual Wealth Management
33
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
OM
34
Opaleye Management
Massachusetts
– -$3.82M -382,000 Closed
PAPAIJV
35
Paragon Associates & Paragon Associates II Joint Venture
Texas
– -$500K -50,000 Closed
DM
36
Deerfield Management
New York
– -$331K -33,117 Closed
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
– -$22K -2,186 Closed
TRCT
38
Tower Research Capital (TRC)
New York
– -$1.15K -122 -99%
Fifth Third Bancorp
39
Fifth Third Bancorp
Ohio
– -$1K -111 Closed
US Bancorp
40
US Bancorp
Minnesota
– -$1K -111 Closed
1
2

LUMO Hedge Fund Activity: Q3 2021 in Review

37 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q3 2021, worth a combined $27.3M — down 15% from $32.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of LUMO and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 7 added.

The largest buyer was Wells Fargo, adding an estimated $950K. The largest seller was Opaleye Management, exiting entirely with an estimated $3.82M sold.

  • 37 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q3 2021, down from 40 in Q2 2021.
  • Funds reported $27.3M of Lumos Pharma, Inc. Common Stock stock for Q3 2021, down 15% quarter-over-quarter.
  • 4 funds opened new Lumos Pharma, Inc. Common Stock positions in Q3 2021 and 7 closed out, a net change of -3 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q3 2021 was Wells Fargo, an estimated $950K added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q3 2021 was Opaleye Management, an estimated $3.82M sold.

Based on aggregated 13F filings for Q3 2021.